Position in VCEL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,225,084
+$5,739,414 QoQ
Shares Held
139,921
+826.8% QoQ
Ownership
0.273%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#61
of 315 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 88%
Shared 5%
None 7%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $148,775,467 across 46 Biotechnology names. VCEL ranks #7 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
538,822 | $61,080,861 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
488,546 | $12,360,212 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
206,405 | $11,810,493 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
141,317 | $11,060,881 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,621 | $10,987,396 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,722 | $6,319,398 | |
| 7 | VCEL |
Vericel Corp
This page
|
139,921 | $6,225,084 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
7,637 | $2,413,979 |
All Filings in VCEL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,225,084 | 139,921 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $485,670 | 15,097 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $459,091 | 12,749 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $483,323 | 10,832 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $597,530 | 10,882 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $480,086 | 11,363 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $516,379 | 11,255 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $663,255 | 12,750 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $411,509 | 11,556 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $388,027 | 11,576 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $443,401 | 11,802 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $346,034 | 11,802 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $318,239 | 12,082 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $281,462 | 12,132 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $309,965 | 12,310 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $527,436 | 13,800 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $278,244 | 7,080 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $525,771 | 10,774 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $308,017 | 5,867 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||